Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

Journal of Clinical Investigation

Volumn 97, Issue 7, 1996, Pages 1655-1665

  Rehermann, Barbara ^a   Lau, Daryl ^b   Hoofnagle, Jay H ^b   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

CTL; HBV; HLA A2; interferon; limiting dilution analysis

Indexed keywords

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; PRIORITY JOURNAL; REMISSION;

EID: 0030008076     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118592     Document Type: Article

References (29)

1. Tiollais., P., C. Pourcel, and A. Dejean. 1985. The hepatitis B virus. Nature (Lond.). 317:489-495.
2. Penna, A., F.V. Chisari, A. Bertoletti, G. Missale, P. Fowler, T. Giuberti, and F. Fiaccadori. 1991. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1565-1570.
3. Missale, G., A, Redeker, J. Person, P. Fowler, S. Guilhot, H.J. Schlicht, C. Ferrari, and F.V. Chisari. 1993. HLA-A31 and Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med 177:751-762.
4. Bertoletti, A., C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H J Schlicht, P. Fowler, S Guilhot, and F.V. Chisari. 1991. HLA class-1 restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad. Sci. USA. 88:10445-10449.
5. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cerny, H.-J. Schlicht, A Vitiello, R. Chesnut, J.L. Person, A.G. Redeker, and F.V. Chisari 1993 HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol 150: 4659-4671.
6. Rehermann, B , P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F.V Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
7. Chisari, F.V., and C. Ferrari. 1996. Immunobiology and pathogenesis of viral hepatitis. In Viral Pathogenesis. N. Nathenson, R. Ahmed, F. Gonzalez-Scarano, D. Griffin, K. Holmes, F.A Murphy, and H.L. Robinson, editors-Raven Press Ltd., New York. In press.
8. Takano, S., O. Yokosuka, F. Imazeki, M. Tagawa, and M. Omata. 1995 Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepalology 21:650-655.
9. Bamaba, V., A. Franco, A. Balsano, C. Alberti, R. Benvenuto, and F Balsano. 1989. Recognition of hepatitis B envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J. Immunol. 143:2650-2655
10. Ferrari, C., A. Penna, T. Giuberti, M J. Tong, E. Ribera, F. Fiaccadori. and F.V. Chisari. 1987 Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol. 139:2050-2058.
11. Bonino, F., F Rosina, M. Rizzetto, R Rizzi, E. Chiaberge, R. Tardanico, F. Callea, and G Verme. 1986. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology. 90:1268-1273.
12. Lohiya, G., S. Lohiya, V.T. Ngo, and R. Crinella. 1986. Epidemiology of hepatitis B e antigen and antibody in mentally retarded HBsAg carriers. Hepatology 6:163-166.
13. Tsai, S.L., M.Y. Chen, M.Y. Lai, P.M. Yang, J.L. Seng, J.H. Huang, L.H Hwang, T.H. Chang, and D.S. Chen. 1992. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J. Clin. Invest. 89:87-96.
14. + T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J. Virol. 69:3358-3368.
15. Alexander, G.J.M., J. Brahm, E.A. Fagan, H.M. Smith, HM. Daniels, A L.W.F. Eddleston, and R. Williams. 1987. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet. ii:66-68.
16. Di Bisceghe, A.M., T.-L. Fong, M.W. Fried, G. Swain, B. Baker, J. Korenman, N.V. Bergasa, J.G. Waggoner, Y. Park, and J.H. Hoofnagle. 1993. A randomized controlled trial of recombinant alpha interferon therapy for chronic hepatitis B. Am. J. Gastroent. 88:1887-1892.
17. Hoofnagle, J.H., M.G. Peters, K.D. Mullen, D.B. Jones, V. Rustgi, A. DiBiscegli, C. Hallahan, Y. Park, C. Meschievitz, and E.A. Jones. 1988. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology. 95:1318-1325.
18. Korenman, J., B. Baker, J. Waggoner, I.E. Everhart, A.M. Di Bisceglie, and J.H. Hoofnagle. 1991. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann. Intern. Med. 114:629-634.
19. Pasek, M., T Goto, W. Gilbert, B. Zink, H. Schaller, P. Mackay, G. Leadbetter, and K. Murray. 1979. Hepatitis B virus genes and their expression in E. Coli. Nature (Lond.). 282:575-579.
20. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant plaques. Mol. Cell. Biol. 5:3403-3409.
21. Schlicht, H.J., and H. Schaller. 1989. The secretory core protein of human hepatitis B virus is expressed on the cell surface. J. Virol. 63:5399-5404
22. Guilhot, S., P. Fowler, G. Portillo, R.F. Margolskee, C. Ferrari, A. Bertoletti, and F.V. Chisari. 1992. Hepatitis B virus (HBV) specific cytolytic T cell response in humans: Production of target cells by stable expression of HBV-encoded proteins in immortalized human B cell lines. J. Virol 66:2670-2678.
23. Fazekas, S., and S. T. Groth. 1982. The evaluation of limiting dilution assays. J. Immunol Methods. R11:R23.
24. Michalak, T.I, C. Pasquinelli, S. Guilhot, and F.V. Chisari. 1994. Hepatitis B virus persistence after recovery from acute viral hepatitis. J. Clin, Invest. 93:230-239.
25. Cerny, A., P. Fowler, M.A. Brothers, M. Houghton, H.J. Schlicht, and F.V. Chisari. 1995. Induction in vitro of a primary human antiviral cytotoxic T cell response Eur. J. Immunol. 25:627-630
26. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A Cerny, H.-J. Schlicht, A. Vitiello, R. Chesnut, J. Person, A.G. Redeker, and F.V. Chisari. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659-4671.
27. Scotto, J., M. Hadchouel, C. Hery, J. Yvart, P. Tiollais, and C. Brechot. 1983. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology. 3: 279-284.
28. Bonino, F., B. Hoyer, J. Nelson, R. Engle, G. Verme, and J. Gerin. 1981. Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology. 1:386-391.
29. Vitiello, A., G. Ishioka, H.M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F.V. Chisari, J. Furze, R. Bartholomeuz, and R.W. Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. 1. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin Invest. 95:341-349.